Six months after Amgen and AstraZeneca reported promising results for Tezspire (tezepelumab) as a potential treatment for ...

Dr. Ransom is a graduate of the University of Iowa College of Medicine (1962) and was certified by the American Board of Allergy and Immunology in 1974. He is a Fellow of the American College of ...

If the symptoms persist beyond 12 weeks of treatment, the sinusitis is labeled as chronic. Bacterial growth on cultures obtained from the nose or nasopharynx, and growth on those obtained with ...

AstraZeneca and Amgen's drug could have a new use after positive Phase 3 study results. Elsewhere, Jazz set new plans for a ...

Have you ever been frustrated by one side of your nose feeling completely blocked while the other is clear? As annoying as it ...

A sinus infection, also known as sinusitis, occurs when the air cavities around your nasal passages become inflamed and ...

AstraZeneca and Amgen's Phase 3 trial data shows Tezspire significantly reduces nasal polyps and congestion in patients with chronic rhinosinusitis with nasal polyps.

Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps and nasal congestion in adults with chronic rhinosinusitis with nasal polyps ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

Symptoms of viruses like COVID and flu overlap with each other, but there are ways you can narrow it down to get the ...

Dr Colin Hopper, Associate Clinical Professor at University College London, President of the International Photodynamic Association, and world-leading expert on photodynamic therapy (also known as ...